Cargando…
Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma
OBJECTIVES: To investigate the utility of three-dimensional (3D) amide proton transfer-weighted (APTw) imaging to differentiate mismatch repair deficient (dMMR) and mismatch repair proficient (pMMR) tumors in endometrioid endometrial adenocarcinoma (EEA). METHODS: Forty-nine patients with EEA underw...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665952/ https://www.ncbi.nlm.nih.gov/pubmed/34894294 http://dx.doi.org/10.1186/s13244-021-01126-y |
_version_ | 1784614111444729856 |
---|---|
author | Li, Yuan Liu, Xinyu Wang, Xiaoqi Lin, Chengyu Qi, Yafei Chen, Bo Zhou, Hailong Wu, Qiaoling Ren, Jing Zhao, Jia Yang, Junjun Xiang, Yang He, Yonglan Jin, Zhengyu Xue, Huadan |
author_facet | Li, Yuan Liu, Xinyu Wang, Xiaoqi Lin, Chengyu Qi, Yafei Chen, Bo Zhou, Hailong Wu, Qiaoling Ren, Jing Zhao, Jia Yang, Junjun Xiang, Yang He, Yonglan Jin, Zhengyu Xue, Huadan |
author_sort | Li, Yuan |
collection | PubMed |
description | OBJECTIVES: To investigate the utility of three-dimensional (3D) amide proton transfer-weighted (APTw) imaging to differentiate mismatch repair deficient (dMMR) and mismatch repair proficient (pMMR) tumors in endometrioid endometrial adenocarcinoma (EEA). METHODS: Forty-nine patients with EEA underwent T1-weighted imaging, T2-weighted imaging, 3D APTw imaging, and diffusion-weighted imaging at 3 T MRI. Image quality and measurement confidence of APTw images were evaluated on a 5-point Likert scale. APTw and apparent diffusion coefficient (ADC) values were calculated and compared between the dMMR and pMMR groups and among the three EEA histologic grades based on the Federation of Gynecology and Obstetrics (FIGO) grading system criteria. Student’s t-test, analysis of variance with Scheffe post hoc test, and receiver operating characteristic analysis were performed. Statistical significance was set at p < 0.05. RESULTS: Thirty-five EEA patients (9 with dMMR tumors and 26 with pMMR tumors) with good image quality were enrolled in quantitative analysis. APTw values were significantly higher in the dMMR group than in the pMMR group (3.2 ± 0.3% and 2.8 ± 0.5%, respectively; p = 0.019). ADC values of the dMMR and pMMR groups were 0.874 ± 0.104 × 10(−3) mm(2)/s and 0.903 ± 0.100 × 10(−3) mm(2)/s, respectively. No significant between-group difference was noted (p = 0.476). No statistically significant differences were observed in APTw values or ADC values among the three histologic grades (p = 0.766 and p = 0.295, respectively). CONCLUSIONS: APTw values may be used as potential imaging markers to differentiate dMMR from pMMR tumors in EEA. |
format | Online Article Text |
id | pubmed-8665952 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-86659522021-12-27 Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma Li, Yuan Liu, Xinyu Wang, Xiaoqi Lin, Chengyu Qi, Yafei Chen, Bo Zhou, Hailong Wu, Qiaoling Ren, Jing Zhao, Jia Yang, Junjun Xiang, Yang He, Yonglan Jin, Zhengyu Xue, Huadan Insights Imaging Original Article OBJECTIVES: To investigate the utility of three-dimensional (3D) amide proton transfer-weighted (APTw) imaging to differentiate mismatch repair deficient (dMMR) and mismatch repair proficient (pMMR) tumors in endometrioid endometrial adenocarcinoma (EEA). METHODS: Forty-nine patients with EEA underwent T1-weighted imaging, T2-weighted imaging, 3D APTw imaging, and diffusion-weighted imaging at 3 T MRI. Image quality and measurement confidence of APTw images were evaluated on a 5-point Likert scale. APTw and apparent diffusion coefficient (ADC) values were calculated and compared between the dMMR and pMMR groups and among the three EEA histologic grades based on the Federation of Gynecology and Obstetrics (FIGO) grading system criteria. Student’s t-test, analysis of variance with Scheffe post hoc test, and receiver operating characteristic analysis were performed. Statistical significance was set at p < 0.05. RESULTS: Thirty-five EEA patients (9 with dMMR tumors and 26 with pMMR tumors) with good image quality were enrolled in quantitative analysis. APTw values were significantly higher in the dMMR group than in the pMMR group (3.2 ± 0.3% and 2.8 ± 0.5%, respectively; p = 0.019). ADC values of the dMMR and pMMR groups were 0.874 ± 0.104 × 10(−3) mm(2)/s and 0.903 ± 0.100 × 10(−3) mm(2)/s, respectively. No significant between-group difference was noted (p = 0.476). No statistically significant differences were observed in APTw values or ADC values among the three histologic grades (p = 0.766 and p = 0.295, respectively). CONCLUSIONS: APTw values may be used as potential imaging markers to differentiate dMMR from pMMR tumors in EEA. Springer International Publishing 2021-12-11 /pmc/articles/PMC8665952/ /pubmed/34894294 http://dx.doi.org/10.1186/s13244-021-01126-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Li, Yuan Liu, Xinyu Wang, Xiaoqi Lin, Chengyu Qi, Yafei Chen, Bo Zhou, Hailong Wu, Qiaoling Ren, Jing Zhao, Jia Yang, Junjun Xiang, Yang He, Yonglan Jin, Zhengyu Xue, Huadan Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma |
title | Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma |
title_full | Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma |
title_fullStr | Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma |
title_full_unstemmed | Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma |
title_short | Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma |
title_sort | using amide proton transfer-weighted mri to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665952/ https://www.ncbi.nlm.nih.gov/pubmed/34894294 http://dx.doi.org/10.1186/s13244-021-01126-y |
work_keys_str_mv | AT liyuan usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT liuxinyu usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT wangxiaoqi usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT linchengyu usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT qiyafei usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT chenbo usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT zhouhailong usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT wuqiaoling usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT renjing usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT zhaojia usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT yangjunjun usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT xiangyang usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT heyonglan usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT jinzhengyu usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma AT xuehuadan usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma |